ArticleOncotarget2016

Utility of patient-derived lymphoblastoid cell lines as an ex vivo capecitabine sensitivity prediction model for breast cancer patients.

Gladys Morrison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.